Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Tenofovir Alafenamide: The Future of Pre-Exposure Prophylaxis?
Kenneth Mayer, MD, explains why tenofovir alafenamide may be the future of pre-exposure prophylaxis.
New Therapies on Horizon May Positively Impact PrEP Adherence & Treatment
Kenneth Mayer, MD, discusses new therapies that may have a positive impact on pre-exposure prophylaxis adherence and treatment.
What is The Fact-Track Cities Initiative?
Benjamin Young, MD, PhD, explains the Fast-Track Cities initiative.
What Are Some of the Challenges of Improving PrEP Delivery & Adherence?
Kenneth Mayer, MD, discusses the current challenges of improving pre-exposure prophylaxis delivery and adherence in the United States.  
What Are Some Concerns Regarding Pre-Exposure Prophylaxis Treatment?
Kenneth Mayer, MD, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.
Cities Hold a Large Share of the Global HIV Burden
Benjamin Young, MD, PhD, shares how many catalysts for the HIV epidemic exist within cities.
The Past, Present, and Future of HIV Management
Eric S. Daar, MD; Joseph Eron, MD; Ian Frank, MD; Peter L. Salgo, MD; and Paul E. Sax, MD, discuss the changing landscape in HIV management and the current unmet needs.
Long-Acting Formulations Emerging in HIV Treatment
Eric S. Daar, MD; Joseph Eron, MD; Ian Frank, MD; Peter L. Salgo, MD; and Paul E. Sax, MD, describe the potential benefits of having a longer-acting formulation available for the treatment of HIV infections.
We break down our top HIV news stories of 2017. Did you read them all?